Anti-interleukin 5 therapies failure criteria in severe asthma: a Delphi-consensus study

Aix Marseille Univ., APHM, Clinique des bronches, de l’allergie et du sommeil, Hôpital Nord, Chemin des Bourrely, 13015 Marseille, France

Department of Respiratory Diseases, Univ. Montpellier, CHU Montpellier, Montpellier, France

Department of Medical Information, Univ. Montpellier, CHU Montpellier, Montpellier, France

Department of Respiratory Diseases, Univ. Montpellier, CHU Montpellier, Montpellier, France

Clinique du Parc, Castelnau-le-Lez, France

Department of Respiratory Diseases, Univ. Montpellier, CHU Montpellier, Montpellier, France

PhyMedExp, CNRS, INSERM, Univ. Montpellier, CHU Montpellier, Montpellier, France

Clinical Research Initiative In Severe Asthma: a Lever for Innovation & Science (CRISALIS), F-CRIN Network, INSERM US 015, Toulouse, France

Department of Respiratory Diseases, Univ. Montpellier, CHU Montpellier, Montpellier, France

Clinique du Parc, Castelnau-le-Lez, France

Department of Respiratory Diseases, Univ. Montpellier, CHU Montpellier, Montpellier, France

PhyMedExp, CNRS, INSERM, Univ. Montpellier, CHU Montpellier, Montpellier, France

Clinical Research Initiative In Severe Asthma: a Lever for Innovation & Science (CRISALIS), F-CRIN Network, INSERM US 015, Toulouse, France

Hôpital de la Croix-Rousse, Service de Pneumologie, Hospices Civils de Lyon, Lyon, France

Inflammation and Immunity of the Respiratory Epithelium–EA7426 (PI3)–South Medical University Hospital–Lyon 1 Claude Bernard University, Pierre-Bénite, France

Clinical Research Initiative In Severe Asthma: a Lever for Innovation & Science (CRISALIS), F-CRIN Network, INSERM US 015, Toulouse, France

CHU Lille, Service de Pneumologie et Immuno-allergologie, Institut Pasteur Lille, Univ. Lille, Lille, France

Clinical Research Initiative In Severe Asthma: a Lever for Innovation & Science (CRISALIS), F-CRIN Network, INSERM US 015, Toulouse, France

Department of Respiratory Medicine, Toulouse University Hospital Centre, Toulouse, France

Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Inserm U1291, University of Toulouse, CNRS U5282, Toulouse, France

Aix Marseille Univ., APHM, Clinique des bronches allergies et sommeil, Marseille, France

Clinical Research Initiative In Severe Asthma: a Lever for Innovation & Science (CRISALIS), F-CRIN Network, INSERM US 015, Toulouse, France

Groupe Hospitalier Universitaire AP-HP Nord-Université de Paris, Hôpital Bichat, Service de Pneumologie et Centre de Référence constitutif des Maladies Pulmonaires Rares, Inserm UMR 1152, Paris, France

Aix Marseille Univ., APHM, Clinique des bronches allergies et sommeil, Marseille, France

Clinical Research Initiative In Severe Asthma: a Lever for Innovation & Science (CRISALIS), F-CRIN Network, INSERM US 015, Toulouse, France

Aix Marseille Univ., INSERM U1263, INRA 1260 (C2VN), Marseille, France

Aix Marseille Univ., APHM, Clinique des bronches allergies et sommeil, Marseille, France

Clinical Research Initiative In Severe Asthma: a Lever for Innovation & Science (CRISALIS), F-CRIN Network, INSERM US 015, Toulouse, France

Aix Marseille Univ., INSERM U1263, INRA 1260 (C2VN), Marseille, France

Aix Marseille Univ., CNRS, EFS, ADES, Marseille, France


留言 (0)

沒有登入
gif